IMV

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMV and buy or sell other stocks, ETFs, and their options commission-free!

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. 

CEO
Andrew Hall
CEOAndrew Hall
Employees
—
Employees—
Headquarters
Dartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded
2007
Founded2007
Employees
—
Employees—

IMV Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
1.50
Average volume1.50
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.0195
52 Week high$0.0195
52 Week low
—
52 Week low—

Stock Snapshot

IMV(IMV) stock is priced at $0.82.

On 2026-09-27, IMV(IMV) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.5.

People also own

Based on the portfolios of people who own IMV. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.